Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The objective of this study was designed to extend the application of poly(epsilon-caprolactone) (
PCL
) in delivery of macromolecular proteins. The strategy applied here is to create a porous structure in
PCL
films in order to control the diffusion rate of protein. Various amounts of both high-molecular-weight and low-molecular-weight poly(ethylene glycol) (PEG) were used as pore-forming agents. The porous films were prepared by a solvent-casting-leaching method. The thicknesses of the prepared films were controlled to be in the range of 75.3 +/- 0.6 similar 81.7 +/- 0.6 mum. The pore fraction of films was determined to be 27.7 +/- 1.0% similar 52.5 +/- 0.8% for PEG(10000) and 26.6 +/- 1.8% similar 48.8 +/- 1.4% for PEG(4000). The pore fraction initially increased with increasing amounts of PEG, independent of the molecular weight of PEG. In the permeation study,
lysozyme
was used as a model diffuser. The permeation rate of protein increased as the pore fraction of films increased, especially when 30 similar 40% of PEG was added initially, and this phenomenon was more prominent when low-molecular-weight PEG was used. This result was probably due to the highly porous structure creating interconnected channels in the films, further enhancing protein diffusion. In addition, the size of micropores formed by PEG(4000) was observed to be larger than by PEG(10000), which also accounted for faster permeation rate of
lysozyme
through
PCL
-PEG(4000) porous films.
...
PMID:Permeation of protein from porous poly(epsilon-caprolactone) films. 1187 Jun 57
A one-step, mild procedure based on coaxial electrospinning was developed for incorporation and controlled release of two model proteins, BSA and
lysozyme
, from biodegradable core-shell nanofibers with
PCL
as shell and protein-containing PEG as core. The thickness of the core and shell could be adjusted by the feed rate of the inner dope, which in turn affected the release profiles of the incorporated proteins. It was revealed that the released
lysozyme
maintained its structure and bioactivity. The current method may find wide applications for controlled release of proteins and tissue engineering.
...
PMID:A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. 1615 37
Poly(epsilon-caprolactone) (
PCL
)/chitin and
PCL
/chitosan blend films with compositional gradients were successfully fabricated by a dissolution/diffusion method; that is, repeatedly pouring the
PCL
/chitin (or
PCL
/chitosan) blend solutions, with variable composition, onto polysaccharide layers. The compositional gradient structure in the resulting films was characterized by polarized optic microscopy, ATR-FT-IR and trans-FT-IR microscopic spectroscopy. Enzymatic degradability of the
PCL
/chitin and
PCL
/chitosan blend films with compositional gradients in the presence of
lysozyme
was compared with those of homogeneous films and two-layer films. It was found that the degradation rate of
PCL
/chitin blend films with a compositional gradient was far lower than that of the neat chitin film, whereas the degradation rate of
PCL
/chitosan blend films with a compositional gradient was close to that of the neat chitosan film. The suppression of the chitosan crystallization, which accelerates the enzymatic degradation, at the surface of
PCL
/chitosan films with a compositional gradient was much more severe than that for
PCL
/chitin films with a compositional gradient.
...
PMID:Poly(epsilon-caprolactone)/chitin and poly(epsilon-caprolactone)/chitosan blend films with compositional gradients: fabrication and their biodegradability. 1653 61
Chitosan is a well sought-after polysaccharide in biomedical applications and has been blended with various macromolecules to mitigate undesirable properties. However, the effects of blending on the unique antibacterial activity of chitosan as well as changes in fatigue and degradation properties are not well understood. The aim of this work was to evaluate the anti-bacterial properties and changes in physicochemical properties of chitosan upon blending with synthetic polyester poly(epsilon-caprolactone) (
PCL
). Chitosan and
PCL
were homogeneously dissolved in varying mass ratios in a unique 77% acetic acid in water mixture and processed into uniform membranes. When subjected to uniaxial cyclical loading in wet conditions, these membranes sustained 10 cycles of predetermined loads up to 1 MPa without break. Chitosan was anti-adhesive to Gram-positive Streptococcus mutans and Gram-negative Actinobacillus actinomycetemcomitans bacteria. Presence of
PCL
compromised the antibacterial property of chitosan. Four-week degradation studies in PBS/
lysozyme
at 37 degrees C showed initial weight loss due to chitosan after which no significant changes were observed. Molecular interactions between chitosan and
PCL
were investigated using Fourier transform infrared spectroscopy (FTIR) which showed no chemical bond formations in the prepared blends. Investigation by wide-angle X-ray diffraction (WAXD) indicated that the crystal structure of individual polymers was unchanged in the blends. Dynamic mechanical and thermal analysis (DMTA) indicated that the crystallinity of
PCL
was suppressed and its storage modulus increased with the addition of chitosan. Analysis of surface topography by atomic force microscopy (AFM) showed a significant increase in roughness of all blends relative to chitosan. Observed differences in biological and anti-bacterial properties of blends could be primarily attributed to surface topographical changes.
...
PMID:Blending chitosan with polycaprolactone: effects on physicochemical and antibacterial properties. 1660 30
A blend mixture of biodegradable poly(epsilon-caprolactone) (
PCL
) and poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol)-NH(2) (PLGA-b-PEG-NH(2)) block copolymer was electrospun to produce surface functionalized nanofibers. The resulting nanofibrous mesh with primary amine groups on the surface was applied for immobilization of biologically active molecules using
lysozyme
as a model enzyme. Lysozyme was immobilized via covalent conjugation by using a homobifunctional coupling agent. The nanofibrous mesh could immobilize a far greater amount of
lysozyme
on the surface with concomitantly increased activity, primarily due to its larger surface area, compared to that of the solvent casting film. It was also found that the enzyme immobilization process slightly altered thermal and pH-dependent catalytic activity profiles compared to those of native
lysozyme
. The results demonstrated the surface functionalized electrospun nanofibrous mesh could be used as a promising material for immobilizing a wide range of bioactive molecules.
...
PMID:Surface functionalized electrospun biodegradable nanofibers for immobilization of bioactive molecules. 1688 87
A blend mixture of poly(epsilon-caprolactone) (
PCL
) and poly(ethylene oxide) (PEO) was electrospun to produce fibrous meshes that could release a protein drug in a controlled manner. Various biodegradable polymers, such as poly(l-lactic acid) (PLLA), poly(epsilon-caprolactone) (
PCL
), and poly(d,l-lactic-co-glycolic acid) (PLGA) were dissolved, along with PEO and
lysozyme
, in a mixture of chloroform and dimethylsulfoxide (DMSO). The mixture was electrospun to produce
lysozyme
loaded fibrous meshes. Among the polymers, the
PCL
/PEO blend meshes showed good morphological stability upon incubation in the buffer solution, resulting in controlled release of
lysozyme
over an extended period with reduced initial bursts. With varying the
PCL
/PEO blending ratio, the release rate of
lysozyme
from the corresponding meshes could be readily modulated. The
lysozyme
release was facilitated by increasing the amount of PEO, indicating that entrapped
lysozyme
was mainly released out by controlled dissolution of PEO from the blend meshes. Lysozyme released from the electrospun fibers retained sufficient catalytic activity.
...
PMID:Controlled protein release from electrospun biodegradable fiber mesh composed of poly(epsilon-caprolactone) and poly(ethylene oxide). 1732 Oct 84
In this study, the concept of hydrophobic ion pairing was adopted for incorporating
lysozyme
into electrospun poly(epsilon-caprolactone) (
PCL
)/poly(ethylene glycol) (PEG) non-woven membranes. The solubility of
lysozyme
in organic solvent was enhanced through the formation of
lysozyme
-oleate complexes, which could be directly loaded into
PCL
/PEG membranes using electrospinning technique. The resultant
PCL
/PEG nanofibers have a compact structure with an average diameter ranged from about 0.4 microm to 0.9 microm. The addition of PEG into the
PCL
nanofibers not only improved the hydrophilicity of the membrane, but also played an important role on in vitro
lysozyme
release rate. It was found that the release rate of
lysozyme
was enhanced with the increase of PEG content. In addition, the increase of salt concentration in the release medium accelerated
lysozyme
release. It has also been shown that the released
lysozyme
retained most of its enzymatic activity.
...
PMID:Encapsulation and controlled release of lysozyme from electrospun poly(epsilon-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme-oleate complexes. 1766 13
Chitosan is a well sought-after polysaccharide in biomedical applications due to its biocompatibility, biodegradability to non-toxic substances, and ease of fabrication into various configurations. However, alterations in the anti-bacterial properties of chitosan in various forms is not completely understood. The objective of this study was to evaluate the anti-bacterial properties of chitosan matrices in different configurations against two pathogens-Gram-positive Streptococcus mutans and Gram-negative Actinobacillus actinomycetemcomitans. Two-dimensional (2-D) membranes and three-dimensional (3-D) porous scaffolds were synthesized by air drying and controlled-rate freeze drying. Matrices were suspended in bacterial broths with or without
lysozyme
(enzyme that degrades chitosan). Influences of pore size, blending with Polycaprolactone (
PCL
, a synthetic polymer), and neutralization process on bacterial proliferation were studied. Transient changes in optical density of the broth, adhesion characteristics, viability, and contact-dependent bacterial activity were assessed. 3-D porous scaffolds were more effective in reducing the proliferation of S. mutans in suspension than 2-D membranes. However, no significant differences were observed on the proliferation of A. actinomycetemcomitans. Presence of
lysozyme
significantly increased the antibacterial activity of chitosan against A. actinomycetemcomitans. Pore size did not affect the proliferation kinetics of either species, with or without
lysozyme
. NaOH neutralization of chitosan increased bacterial adhesion whereas ethanol neutralization inhibited adhesion without lowering proliferation. Mat culture tests indicated that chitosan does not allow proliferation on its surface and it loses antibacterial activity upon blending with
PCL
. Results suggest that the chemical and structural characteristics of chitosan-based matrices can be manipulated to influence the interaction of different bacterial species.
...
PMID:Antibacterial activity of chitosan-based matrices on oral pathogens. 1770 12
An efficient living ring-opening polymerization (ROP) of a permethoxylated epsilon-caprolactone [(OMe)CL] catalyzed by yttrium(III) isopropoxide was developed for the synthesis of degradable protein-resistant polymers [P(OMe)CL]. The lactone monomer was efficiently prepared from a reduced sugar, D-dulcitol. Kinetic studies of the ROP revealed a linear dependence of ln[M]0/[M] on polymerization time as well as a linear correlation between the number-averaged molecular weight (M(n)) and monomer conversion; both support it is a living polymerization. A series of block copolymers of our permethoxylated lactone with epsilon-caprolactone [P(OMe)CL-b-
PCL
] were synthesized and fully characterized. In thermal analyses only single T(g)s were observed in all the block copolymers, suggesting that P(OMe)CL and
PCL
blocks are fully miscible. Finally, surface plasmon resonance (SPR) sensograms demonstrated that both P(OMe)CL and the P(OMe)CL-b-
PCL
block copolymers exhibit excellent resistance to fibrinogen and
lysozyme
.
...
PMID:Living ring-opening polymerization of a carbohydrate-derived lactone for the synthesis of protein-resistant biomaterials. 1822 Mar 47
Nerve guides are cylindrical conduits of either biologically based or synthetic materials that are used to bridge nerve defects. While it is well known that a critical aspect of nerve regeneration is the delivery of oxygen and nutrients to the surviving nerve tissue, several guide parameters that determine the permeability of nerve guides to nutrients are often overlooked. We have reproducibly manufactured poly(caprolactone) (
PCL
) nerve guides of tailored porosity percentage, wall thickness and pore diameter through a dip-coating/salt-leaching technique. In this study, these three parameters were varied to measure the response of glucose and
lysozyme
diffusion through the guide wall. In addition, nerve guide permeability following protein fouling studies was examined. Based on the results from this study, it was determined that at high porosity percentages (80%), decreasing the pore diameter (10-38microm) was a measurable method of decreasing the
lysozyme
permeability of
PCL
nerve guides while not creating a loss of glucose permeability.
PCL
fouling studies were used to fine-tune the desirable nerve guide wall thickness. Results indicated that nerve guides 0.6mm thick decreased the loss of
lysozyme
to almost 10% without significantly diminishing glucose (nutrient) permeability. These results will be utilized to optimize nerve guide parameters for future in vivo applications.
...
PMID:Diffusion of soluble factors through degradable polymer nerve guides: Controlling manufacturing parameters. 1936 23
1
2
Next >>